Focus Partners Wealth

Position in LNTH — Lantheus Holdings, Inc.

CIK 1542153 ST LOUIS, MO

Position in LNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,500,414

+$282,961 QoQ

Shares Held

72,517

-7.5% QoQ

Ownership

0.111%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Focus Partners Wealth holds $54,434,760 across 17 Drug Manufacturers - Specialty & Generic names. LNTH ranks #4 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	137,784	$16,287,446
2	NBIX	Neurocrine Biosciences Inc	80,335	$10,583,332
3	TAK	Takeda Pharmaceutical Co Ltd	482,387	$8,933,807
4	LNTH	Lantheus Holdings, Inc. This page	72,517	$5,500,414
5	UTHR	UNITED THERAPEUTICS Corp	5,854	$3,471,304
6	ALKS	Alkermes plc.	77,052	$2,724,558
7	HLN	Haleon plc	195,548	$1,957,435
8	VTRS	Viatris Inc	132,034	$1,783,779

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,500,414	72,517	-7.5%	Shares	Sole	2026-05-15
2025-12-31	$5,217,453	78,399	-2.2%	Shares	Sole	2026-02-13
2025-09-30	$4,111,149	80,155	-1.0%	Shares	Sole	2025-11-14
2025-06-30	$6,624,684	80,927	-3.0%	Shares	Sole	2025-08-14
2025-03-31	$8,144,720	83,450	-6.5%	Shares	Sole	2025-05-20
2024-12-31	$7,987,257	89,283	-0.7%	Shares	Sole	2025-05-29
2024-09-30	$9,864,769	89,884	-55.3%	Shares	Sole	2024-11-14
2024-06-30	$16,160,288	201,274	+15.7%	Shares	Sole	2024-08-15
2024-03-31	$10,823,660	173,902	+46.6%	Shares	Sole	2024-05-16
2023-12-31	$7,352,642	118,591	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.